Press release
Bladder Cancer Treatment Market 2018 Analysis Top Players are GSK, Eli Lilly and Company, AstraZeneca, TARIS Biomedical, Bristol-Myers Squibb, Celgene, Sanofi, Roche, Novartis, Pfizer , Accord Healthcare, Merck, Sarepta Therapeutics, Allergan
Global Bladder Cancer Treatment Market– Industry Trends and Forecast to 2025
Global Bladder Cancer Treatment Market, By Type (Urothelial Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma), By Treatment (Surgery, Chemotherapy, Immunotherapy, Radiation Therapy), By Major Test (Biopsy, Cystoscopy, Urine Cytology, Urine Analysis, Bladder Ultrasound), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends & Forecast to 2025
Download PDF Sample Copy of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-bladder-cancer-treatment-market
Market Analysis:
Global Bladder Cancer Treatment Market is set to witness a CAGR of 4.5% in the forecast period of 2018 to 2025. From its initial estimated value of USD 241 million in 2018, it is set to be rising up to US 327.9 million by 2025.
Market Definition:
Bladder Cancer is an anomaly of involuntary cell growth, in the lining of the bladder, which is cancerous in nature and even spread through the muscular wall. It is the most recurring of all the malign cancers found in the world.
Bladder Cancer is caused by smoking, which is not a well-known fact amongst the people, other major cancer causes are tobacco consumption, prolonged exposure to radiation, and chronic bladder infection.
Key Market Competitors:
• GlaxoSmithKline plc.,
• Eli Lilly & Company,
• AstraZeneca plc.,
• Taris Biomedical LLC.,
• Bristol-Myers Squibb,
• Celgene Corporation,
• Sanofi S.A.,
• F. Hoffmann-La Roche Ltd.,
• Novartis AG,
• Pfizer Inc.,
• Accord Healthcare,
• Merck & Co.,
• Sarepta Therapeutics,
• Allergan,
• Bedford Lab,
• Achieve Life Sciences Inc.,
• Astellas Pharma Inc.,
• Seattle Genetics Inc.,
• Cold Genesys Inc.,
• Sesen Bio,
• FKD Therapies Oy,
• Genentech Inc.,
Are few of the major competitors currently working on the Bladder Cancer Treatment market
To Avail 10% Discount on This Report Mail us on:- sopan.gedam@databridgemarketresearch.com
Market Drivers:
• Increased cases of Bladder Cancer, especially in developed regions pushing the market growth forward
• Rise in public awareness, technological advancements and advanced health care services are rising the market high
Market Restraints:
• High rate of failure in the diagnostic and detection of cancerous cells causes the market to be restricted
• Asymptomatic nature of these bladder cancer cases causes the market to be restricted
Competitive Analysis:
The Global Bladder Cancer Treatment Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Bladder Cancer Treatment market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Market Segmentation:
• By Type
o Urothelial Carcinoma (Begins with the cells located in the lining of the bladder)
o Squamous Cell Carcinoma (Begins with the squamous cells, develops in the bladder, following prolonged irritation and infection)
o Adenocarcinoma (Begins in the secretory cells, glandular located in the lining of the bladder, it’s a quite rare condition)
• By Treatment
o Surgery (Transurethral bladder tumor resection, Cystectomy, Urinary Diversion)
o Chemotherapy (Intravescial Chemotherapy, Systemic Chemotherapy)
o Immunotherapy (Intravescial Therapy, Interferon Therapy)
o Radiation
• By Test
o Biopsy
o Cystoscopy
o Urine Cytology
o Urine Analysis
o Bladder Ultrasound
• By Geography
o North America
o South America
o Europe
o Asia-Pacific
o Middle East & Africa
Key Developments in the Market:
• In May 2017, US FDA approved Bavencio produced by Pfizer Inc., to treat advanced stages of Bladder Cancer
• In December 2017, Bristol-Myers Squibb and Taris Biomedical LLC., entered into collaboration, to evaluate and check the safety of TAR-200 (GemRIS™) of Taris Biomedical LLC., with the combination of programmed death-1 (PD-1) immune checkpoint inhibitor, Opdivo (nivolumab) by Bristol-Myers Squibb.
Key Insights in the report:
• The key market players are analyzed and their effects on the market is also observed
• Market analysis is conducted for the forecast period of 2018 to 2025, and the market segmentations are observed during that period
• The market drivers and restraints have been clearly analyzed for the effect that they have over the market in the forecast period of 2018 to 2025
To Inquire before Buy Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bladder-cancer-treatment-market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bladder Cancer Treatment Market 2018 Analysis Top Players are GSK, Eli Lilly and Company, AstraZeneca, TARIS Biomedical, Bristol-Myers Squibb, Celgene, Sanofi, Roche, Novartis, Pfizer , Accord Healthcare, Merck, Sarepta Therapeutics, Allergan here
News-ID: 1318639 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for Bladder
Overactive Bladder (OAB) - Drug Pipeline Landscape, 2022
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women.
The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking.
The most common symptoms…
Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market …
As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The disease in which cancerous cells form in the tissues of the bladder is known as bladder cancer.
Download Free PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/239
There…
Global Bladder Scanners Sales Market Report 2018
This report studies the global Bladder Scanners market status and forecast, categorizes the global Bladder Scanners market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of…
Bladder Cance rMarket entry and expansion strategies
MarketResearchReports.Biz adds “Global Bladder Cancer Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Bladder Cancer and the growth estimates for the forecasted period.
Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder…
Bladder Cancer Pharmaceutical and Healthcare Analysis Information
Summary
Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, sex and color, certain parasitic infections. Treatment…
Bladder Scanners Market Research Report 2011-2023
Browse full table of contents and data tables at : https://www.reportsandmarkets.com/reports/global-bladder-scanners-market-research-report-2011-2023-1476292
Summary
A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels.
Request a sample copy at : https://www.reportsandmarkets.com/sample-request/global-bladder-scanners-market-research-report-2011-2023-1476292
The type of scanner is a niche ultrasound system that provides fast…
